Aging is the major cause of sarcopenia, which explains to some extent the higher risk of falling in elderly compared with young people. Greater incidence of metabolic disorder, insulin resistance, and chronic inflammation in elderly is also closely associated with sarcopenia. Long-term reduction in muscle mass directly decreases physical performance, which in turn affects quality of life and physical independence on daily activity. These outcomes implicate a significant amount of medical burden of the society. This paper reviews the current knowledge regarding the mechanism and the clinical outcome of muscle loss during aging process. Recommended intervention aimed to attenuate the age-dependent sarcopenia are also described.